StockData
InfuSystem Holdings, Inc logo

InfuSystem Holdings, Inc (INFU) stock

INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 13/302% above fair value
$14.79+0.00 (0.00%)

Close on Nov 17, 2026Market cap $294.58MP/E 36.1Yield –

InfuSystem total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

InfuSystem's total debt was $20.42M at Jun 30, 2026. For fiscal 2025 it was $19.63M, down 17.8% from the year before. Over ten years it grew -3.6% a year on average. The highest annual figure on record is $38.80M in fiscal 2020.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$19.63M-17.8%
FY2024Dec 31, 2024$23.86M-18.0%
FY2023Dec 31, 2023$29.10M-12.2%
FY2022Dec 31, 2022$33.16M+0.2%
FY2021Dec 31, 2021$33.10M-14.7%
FY2020Dec 31, 2020$38.80M+1.1%
FY2019Dec 31, 2019$38.38M+13.7%
FY2018Dec 31, 2018$33.75M+18.9%
FY2017Dec 31, 2017$28.39M-11.0%
FY2016Dec 31, 2016$31.89M+12.3%
FY2015Dec 31, 2015$28.39M+11.4%
FY2014Dec 31, 2014$25.48M-4.7%
FY2013Dec 31, 2013$26.73M-14.5%
FY2012Dec 31, 2012$31.27M+7.4%
FY2011Dec 31, 2011$29.13M-9.5%
FY2010Dec 31, 2010$32.20M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$20.42M-22.5%
Q1 FY2026Mar 31, 2026$19.65M-31.6%
Q4 FY2025Dec 31, 2025$19.63M-17.8%
Q3 FY2025Sep 30, 2025$20.93M-25.2%
Q2 FY2025Jun 30, 2025$26.35M-22.9%
Q1 FY2025Mar 31, 2025$28.71M-4.1%
Q4 FY2024Dec 31, 2024$23.86M-18.0%
Q3 FY2024Sep 30, 2024$27.98M-14.3%
Q2 FY2024Jun 30, 2024$34.17M-5.5%
Q1 FY2024Mar 31, 2024$29.93M-17.7%
Q4 FY2023Dec 31, 2023$29.10M-12.2%
Q3 FY2023Sep 30, 2023$32.66M-5.2%
Q2 FY2023Jun 30, 2023$36.14M+7.3%
Q1 FY2023Mar 31, 2023$36.39M+4.1%
Q4 FY2022Dec 31, 2022$33.16M+0.2%
Q3 FY2022Sep 30, 2022$34.46M+11.5%
Q2 FY2022Jun 30, 2022$33.69M+3.8%
Q1 FY2022Mar 31, 2022$34.95M+7.8%
Q4 FY2021Dec 31, 2021$33.10M-14.7%
Q3 FY2021Sep 30, 2021$30.90M-11.2%
Q2 FY2021Jun 30, 2021$32.46M-20.6%
Q1 FY2021Mar 31, 2021$32.42M-18.2%
Q4 FY2020Dec 31, 2020$38.80M+1.1%
Q3 FY2020Sep 30, 2020$34.79M-6.8%
Q2 FY2020Jun 30, 2020$40.87M+21.8%
Q1 FY2020Mar 31, 2020$39.62M+20.6%
Q4 FY2019Dec 31, 2019$38.38M+13.7%
Q3 FY2019Sep 30, 2019$37.35M+11.7%
Q2 FY2019Jun 30, 2019$33.56M+34.3%
Q1 FY2019Mar 31, 2019$32.86M+27.6%
Q4 FY2018Dec 31, 2018$33.75M+18.9%
Q3 FY2018Sep 30, 2018$33.44M+13.8%
Q2 FY2018Jun 30, 2018$25.00M-20.3%
Q1 FY2018Mar 31, 2018$25.76M-15.2%
Q4 FY2017Dec 31, 2017$28.39M-11.0%
Q3 FY2017Sep 30, 2017$29.38M-24.0%
Q2 FY2017Jun 30, 2017$31.38M–
Q1 FY2017Mar 31, 2017$30.37M–
Q4 FY2016Dec 31, 2016$31.89M–
Q3 FY2016Sep 30, 2016$38.64M–

More InfuSystem figures

See a number that looks wrong?